Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1062.29% is 21% above its 5-year average of -1337.00%, near the high end of its 5-year range (-21079.48%–2603.86%).
671.21% below its 12-month average of -137.74%.
Reported quarterly operating margin; no daily interpolation. Q3 FY2026 (2026-06-30): -1522.62%.
OPERATING MARGIN
-1062.29%
OPERATING MARGIN AVG TTM
-137.74%
OPERATING MARGIN AVG 3Y
-1334.42%
OPERATING MARGIN AVG 5Y
-1337.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-671.21%
CURRENT VS 3Y AVG
+20.39%
CURRENT VS 5Y AVG
+20.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Optimi Health Corp.
Market Cap
$13.48M
Operating Margin
-1062.29%
TTM Avg
-137.74%
3Y Avg
-1334.42%
5Y Avg
-1337.00%
Market Cap
$13.72M
Operating Margin
-859.22%
TTM Avg
-477.88%
3Y Avg
-341.34%
5Y Avg
-316.87%
Market Cap
$12.88M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.77M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.83M
Operating Margin
-1053.14%
TTM Avg
-1090.26%
3Y Avg
-1143.76%
5Y Avg
-1293.19%
Market Cap
$12.95M
Operating Margin
-33.37%
TTM Avg
-42.32%
3Y Avg
-69.57%
5Y Avg
-60.22%
Market Cap
$12.94M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Optimi Health Corp. (OPTH) | $13.48M | -1062.29% | -137.74% | -1334.42% | -1337.00% |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | -859.22% | -477.88% | -341.34% | -316.87% |
| Passage Bio, Inc. (PASG)vs › | $12.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Sintx Technologies, Inc. (SINT)vs › | $13.83M | -1053.14% | -1090.26% | -1143.76% | -1293.19% |
| IN8bio, Inc. (INAB)vs › | $13.91M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cytosorbents Corporation (CTSO)vs › | $12.95M | -33.37% | -42.32% | -69.57% | -60.22% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lantern Pharma Inc. (LTRN)vs › | $12.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dare Bioscience, Inc. (DARE)vs › | $12.54M | -1315.51% | -120503.86% | -60605.86% | -40403.91% |
Gross Margin
-486.4%
Operating Margin
-1062.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1522.62% |
| 2026-03-31 | -1363.73% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 2603.86% |
| 2025-06-30 | -406.22% |
| 2025-03-31 | -1615.01% |
| 2024-12-31 | -497.73% |
| 2024-09-30 | -2743.92% |
| 2024-06-30 | -851.19% |
| 2024-03-31 | -1626.40% |
| 2023-12-31 | -1099.33% |
| 2023-09-30 | -6523.15% |
| 2023-06-30 | -2952.47% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -1819.33% |
| 2022-09-30 | -3405.55% |
| 2022-06-30 | -2917.17% |
| 2022-03-31 | -21079.48% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | 0.00% |
